A University of Minnesota Medical School research team has found that giving iron supplements to children living with human immunodeficiency virus (HIV) in sub-Saharan Africa could be an important first step in optimizing brain development.
CC-98633 by Bristol-Myers Squibb for Relapsed Multiple Myeloma: Likelihood of Approval
CC-98633 is under clinical development by Bristol-Myers Squibb and currently in Phase I for Relapsed Multiple Myeloma.